Ana Barac, MD, PhD, Jennifer Liu, MD, and Bonnie Ky, MD, MSCE, discuss the role of cardiac magnetic resonance and strain imaging in cardio-oncology.
Stephen Nicholls, MD, shares his experience starting a cardio-oncology service in Australia. Moderated by Alexandra Murphy, MD, PhD.
Zhicheng Hu, MD, and Edward Mei, MD, discuss atrial fibrillation burden and management in China.
Commentary by Dr. Candice Silversides and Dr. Valentin Fuster
Commentary by Dr. Emile Daoud
Commentary by Dr. Emile Daoud
Commentary by Dr. Douglas Mann and Dr. Elena Amin and Mr. Seth Wagner
Commentary by Dr. Sadeer Al-Kindi and Dr. Mohamad Alkhouli
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Commentary by Dr. Candice Silversides
Dimitrios Farmakis, MD, PhD, and Bonnie Ky, MD, MSCE, discuss SGLT-2 inhibitors and genetics, and applications for cardio-oncology practice.
James Januzzi, MD, and Bonnie Ky, MD, MSCE discuss the discovery of novel biomarkers of cancer therapy-related cardiotoxicity. Moderated by Nicholas Wilcox, MD, MHS.
Sumanta Pal, MD, discusses the treatment of patients with metastatic renal cell carcinoma (mRCC), management of cardiovascular toxicities associated with therapies for mRCC, and the future treatment landscape of mRCC. Moderated by Sarah Waliany, MD, MS.
Commentary by Drs. Pratik Doshi and Martha Gulati discussing how we can improve diversity, equity, and inclusion efforts across cardiology.